Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a highly heterogeneous tumor, resulting a challenge of developing target therapeutics. Not long ago, immune checkpoint blockade regimens combine with tyrosin kinase inhibitors have evolved frontline options in metastatic RCC, which implies arriv...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Androl Urol
Egile Nagusiak: Liao, Zhuangyao, Yao, Haohua, Wei, Jinhuan, Feng, Zihao, Chen, Wei, Luo, Junhang, Chen, Xu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100830/
https://ncbi.nlm.nih.gov/pubmed/33968649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1348
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak